CD57 antibody (SPRD)

Catalog No. ABIN135803

There is 1 publication for this product available. The Mouse Monoclonal anti-CD57 antibody is suitable to detect CD57 in samples from Human. It has been validated for FACS and IHC.

Quick Overview for CD57 antibody (SPRD) (ABIN135803)

Target: CD57 (B3GAT1) (beta-1,3-Glucuronyltransferase 1 (Glucuronosyltransferase P) (B3GAT1))

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This CD57 antibody is conjugated to SPRD

Application: Flow Cytometry (FACS), Immunohistochemistry (IHC)

Clone: NK-1

Product Details anti-CD57 Antibody (SPRD)

Specificity: Human CD57, Mr 110 kDa

Characteristics: Mouse Anti-Human CD57-SPRD

Purification: Protein A column.

Immunogen: Membrane extract of the human lymphoblastoid cell line HSB-2

Isotype: IgM

Application Details

Application Notes: Working Dilution:
FACS: 10 µL/10^6 cells
Representative data are included in this product insert.

Each laboratory should determine an optimum working titer for use in its particular application. Other applications have not been tested but use in such assays should not necessarily be excluded.

Restrictions: For Research Use only

Handling

Buffer: Product is supplied as 100 tests in 1.0 mL of PBS / NaN3 and a stabilizing agent.

Handling Advice: Do not freeze!
Protect conjugated products from light.
Each reagent is stable for the period shown on the bottle label if stored as directed.

Storage: 4 °C

References for anti-CD57 antibody (SPRD) (ABIN135803)

Franz, Knapp: "Staged Endovascular Repair of Bilateral Internal Iliac Artery Aneurysms." in: Annals of vascular surgery, (2008) (PubMed).

Target Details for CD57

Target: CD57 (B3GAT1) (beta-1,3-Glucuronyltransferase 1 (Glucuronosyltransferase P) (B3GAT1))

Alternative Name: CD57

Background: CD57 represents a 100 kDa oligosaccharide antigenic determinant present on a variety of polypeptides, lipids and chondroitan sulfate proteoglycans. It is expressed on 7-35 % of normal peripheral blood lymphocytes, including subsets of NK cells and CD8+ T lymphocytes. The function of CD57 is unknown.

Pathways: Glycosaminoglycan Metabolic Process